Home > Boards > US Listed > Medical - Equipment > Accuray Inc. (ARAY)

8:41AM Accuray: Presentations at radiation oncology meeting highlight

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 438
Posts 24,495
Boards Moderated 1
Alias Born 09/11/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 6:56:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 4:02:51 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/30/2019 4:03:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 9:26:06 AM
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology... PR Newswire (US) - 5/1/2019 4:10:00 PM
Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System PR Newswire (US) - 4/24/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:06:35 PM
Accuray Reports Fiscal 2019 Third Quarter Results PR Newswire (US) - 4/23/2019 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/3/2019 5:02:00 PM
Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019 PR Newswire (US) - 4/2/2019 7:30:00 AM
Bilkent City Hospital Selects Accuray's Radixact® System PR Newswire (US) - 3/14/2019 11:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2019 5:02:18 PM
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with ... PR Newswire (US) - 2/22/2019 7:30:00 AM
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with ... PR Newswire (US) - 2/22/2019 7:30:00 AM
Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors GlobeNewswire Inc. - 2/20/2019 4:06:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 5:26:03 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 3:56:30 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2019 10:24:25 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/11/2019 8:51:58 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2019 3:50:41 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2019 6:20:30 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/4/2019 10:21:32 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/31/2019 6:41:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/28/2019 7:02:17 AM
Accuray And China Isotope And Radiation Corporation Enter Joint Venture Contract To Manufacture And Sell Radiation Oncology S... PR Newswire (US) - 1/28/2019 6:00:00 AM
surf1944   Monday, 11/05/12 01:36:38 PM
Re: surf1944 post# 1195
Post # of 1222 
8:41AM Accuray: Presentations at radiation oncology meeting highlight CyberKnife prostate outcomes from patients at more than 40 centers (ARAY) 6.91 : Co announced today clinical findings using non-invasive CyberKnife? stereotactic body radiation therapy for the treatment of prostate cancer. Two studies presented at the 54th Annual American Society for Radiation Oncology (ASTRO) Meeting in Boston were selected by ASTRO for presentation to the media at a prostate-focused press conference on Tuesday, October 30, 2012, for which the use of CyberKnife SBRT for prostate cancer represented half of the press conference's focus. Patients were followed for a median of 36 months, and close to half were followed for at least four years, as updated by Dr. Katz during his presentation. Actuarial five-year disease-free survival was 95 percent for low-risk patients, 90 percent for intermediate-risk patients and 80 percent for high-risk patients. These findings compare favorably with other surgical and radiation-based treatments

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist